{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T08:12:31Z","timestamp":1794643951164,"version":"4.9.1"},"reference-count":48,"publisher":"American Association for Cancer Research (AACR)","issue":"5","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The role of mitochondrial dysfunction in cancer has been a subject of great interest and much ongoing investigation. Although most cancer cells harbor somatic mutations in mitochondrial DNA (mtDNA), the question of whether such mutations contribute to the promotion of carcinomas remains unsolved. Here we used trans-mitochondrial hybrids (cybrids) containing a common HeLa nucleus and mtDNA of interest to compare the role of mtDNA against the common nuclear background. We constructed cybrids with or without a homoplasmic pathogenic point mutation at nucleotide position 8,993 or 9,176 in the mtDNA ATP synthase subunit 6 gene (MTATP6) derived from patients with mitochondrial encephalomyopathy. When the cybrids were transplanted into nude mice, the MTATP6 mutations conferred an advantage in the early stage of tumor growth. The mutant cybrids also increased faster than wild type in culture. To complement the mtDNA mutations, we transfected a wild-type nuclear version of MTATP, whose codons were converted to the universal genetic codes containing a mitochondrial target sequence, into the nucleus of cybrids carrying mutant MTATP6. The restoration of MTATP slowed down the growth of tumor in transplantation. Conversely, expression of a mutant nuclear version of MTATP6 in the wild-type cybrids declined respiration and accelerated the tumor growth. These findings showed that the advantage in tumor growth depended upon the MTATP6 function but was not due to secondary nuclear mutations caused by the mutant mitochondria. Because apoptosis occurred less frequently in the mutant versus wild-type cybrids in cultures and tumors, the pathogenic mtDNA mutations seem to promote tumors by preventing apoptosis.<\/jats:p>","DOI":"10.1158\/0008-5472.can-04-2012","type":"journal-article","created":{"date-parts":[[2005,9,15]],"date-time":"2005-09-15T17:28:17Z","timestamp":1126805297000},"page":"1655-1663","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":238,"title":["Positive Contribution of Pathogenic Mutations in the Mitochondrial Genome to the Promotion of Cancer by Prevention from Apoptosis"],"prefix":"10.1158","volume":"65","author":[{"given":"Yujiro","family":"Shidara","sequence":"first","affiliation":[{"name":"1Pathology and Departments of"},{"name":"3Department of Biochemistry and Cell Biology, Institute of Development and Aging Sciences, Graduate School of Medicine, Nippon Medical School, Kawasaki, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumi","family":"Yamagata","sequence":"additional","affiliation":[{"name":"3Department of Biochemistry and Cell Biology, Institute of Development and Aging Sciences, Graduate School of Medicine, Nippon Medical School, Kawasaki, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kanamori","sequence":"additional","affiliation":[{"name":"3Department of Biochemistry and Cell Biology, Institute of Development and Aging Sciences, Graduate School of Medicine, Nippon Medical School, Kawasaki, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutoshi","family":"Nakano","sequence":"additional","affiliation":[{"name":"2Pediatrics, Tokyo Women's Medical University, School of Medicine, Tokyo, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Q.","family":"Kwong","sequence":"additional","affiliation":[{"name":"4Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Manfredi","sequence":"additional","affiliation":[{"name":"4Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Oda","sequence":"additional","affiliation":[{"name":"1Pathology and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Ohta","sequence":"additional","affiliation":[{"name":"3Department of Biochemistry and Cell Biology, Institute of Development and Aging Sciences, Graduate School of Medicine, Nippon Medical School, Kawasaki, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2005,3,7]]},"reference":[{"key":"2022061621062359300_B1","doi-asserted-by":"crossref","unstructured":"Carew JS, Huang P. Mitochondrial defects in cancer. Mol Cancer\u20082002; 1: 9.","DOI":"10.1186\/1476-4598-1-9"},{"key":"2022061621062359300_B2","doi-asserted-by":"crossref","unstructured":"Polyak K, Li Y, Zhu H, et al. Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet\u20081998; 20: 291\u20133.","DOI":"10.1038\/3108"},{"key":"2022061621062359300_B3","doi-asserted-by":"crossref","unstructured":"Fliss MS, Usadel H, Caballero OL, et al. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science\u20082000; 287: 2017\u20139.","DOI":"10.1126\/science.287.5460.2017"},{"key":"2022061621062359300_B4","unstructured":"Liu VW, Shi HH, Cheung AN, et al. High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. Cancer Res\u20082001; 61: 5998\u20136001."},{"key":"2022061621062359300_B5","unstructured":"Parrella P, Xiao Y, Fliss M, et al. Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. Cancer Res\u20082001; 61: 7623\u20136."},{"key":"2022061621062359300_B6","doi-asserted-by":"crossref","unstructured":"Maximo V, Soares P, Lima J, Cameselle-Teijeiro J, Sobrinho-Simoes M. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hurthle cell tumors. Am J Pathol\u20082002; 160: 1857\u201365.","DOI":"10.1016\/S0002-9440(10)61132-7"},{"key":"2022061621062359300_B7","unstructured":"Tan DJ, Bai RK, Wong LJ. Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res\u20082002; 62: 972\u20136."},{"key":"2022061621062359300_B8","doi-asserted-by":"crossref","unstructured":"Yeh JJ, Lunetta KL, van Orsouw NJ, et al. Somatic mitochondrial DNA (mtDNA) mutations in papillary thyroid carcinomas and differential mtDNA sequence variants in cases with thyroid tumours. Oncogene\u20082000; 19: 2060\u20136.","DOI":"10.1038\/sj.onc.1203537"},{"key":"2022061621062359300_B9","doi-asserted-by":"crossref","unstructured":"Coller HA, Khrapko K, Bodyak ND, Nekhaeva E, Herrero-jimenez P, Thilly WG. High frequency of homoplasmic mitochondrial DNA mutations in human tumors can be explained without selection. Nat Genet\u20082001; 28: 147\u201350.","DOI":"10.1038\/88859"},{"key":"2022061621062359300_B10","doi-asserted-by":"crossref","unstructured":"Linnartz B, Anglmayer R, Zanssen S. Comprehensive scanning of somatic mitochondrial DNA alterations in acute leukemia developing from myelodysplastic syndromes. Cancer Res\u20082004; 64: 1966\u201371.","DOI":"10.1158\/0008-5472.CAN-03-2956"},{"key":"2022061621062359300_B11","doi-asserted-by":"crossref","unstructured":"Amuthan G, Biswas G, Zyang SY, Klein-Szanto A, Vijayasarathy C, Avadhani NG. Mitochondria-to-nucleus stress signaling induces phenotypic changes, tumor progression and cell invasion. EMBO J\u20082001; 20: 1910\u201320.","DOI":"10.1093\/emboj\/20.8.1910"},{"key":"2022061621062359300_B12","doi-asserted-by":"crossref","unstructured":"Baysal BE, Ferrell RE, Willett-Brozick JE, et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science\u20082000; 287: 848\u201351.","DOI":"10.1126\/science.287.5454.848"},{"key":"2022061621062359300_B13","doi-asserted-by":"crossref","unstructured":"Niemann S, Muller U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet\u20082000; 26: 268\u201370.","DOI":"10.1038\/81551"},{"key":"2022061621062359300_B14","doi-asserted-by":"crossref","unstructured":"Tomlinson IP, Alam NA, Rowan AJ, et al. Multiple Leiomyoma Consortium. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet\u20082002; 30: 406\u201310.","DOI":"10.1038\/ng849"},{"key":"2022061621062359300_B15","doi-asserted-by":"crossref","unstructured":"Eng C, Kiuru M, Fernandez MJ, Aaltonen LA. A role for mitochondrial enzymes in inherited neoplasia and beyond. Nat Rev Cancer\u20082003; 3: 193\u2013202.","DOI":"10.1038\/nrc1013"},{"key":"2022061621062359300_B16","unstructured":"Holt IJ, Harding AE, Petty RK, Morgan-Hughes JA. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet\u20081990; 46: 428\u201333."},{"key":"2022061621062359300_B17","unstructured":"Tatuch Y, Christodoulou J, Feigenbaum A, et al. Heteroplasmic mtDNA mutation (T-G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet\u20081992; 50: 852\u20138."},{"key":"2022061621062359300_B18","doi-asserted-by":"crossref","unstructured":"King MP, Attardi G. Human cells lacking mtDNA: reputation with exogenous mitochondria by complementation. Science\u20081989; 246: 500\u20133.","DOI":"10.1126\/science.2814477"},{"key":"2022061621062359300_B19","doi-asserted-by":"crossref","unstructured":"Hayashi J-I, Ohta S, Kikuchi A, Takemitsu M, Goto Y, Nonaka I. Introduction of disease-related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondrial dysfunction. Proc Natl Acad Sci U S A\u20081991; 88: 10614\u20138.","DOI":"10.1073\/pnas.88.23.10614"},{"key":"2022061621062359300_B20","doi-asserted-by":"crossref","unstructured":"Manfredi G, Fu J, Ojaimi J, et al. Rescue of a deficiency in ATP synthesis by transfer of MTATP6, a mitochondrial DNA-encoded gene, to the nucleus. Nat Genet\u20082002; 30: 394\u20139.","DOI":"10.1038\/ng851"},{"key":"2022061621062359300_B21","doi-asserted-by":"crossref","unstructured":"Nakano K, Ohsawa I, Yamagata K, et al. Continuous culture of novel mitochondrial cells lacking nuclei. Mitochondrion\u20082003; 3: 21\u20137.","DOI":"10.1016\/S1567-7249(03)00056-4"},{"key":"2022061621062359300_B22","doi-asserted-by":"crossref","unstructured":"Thyagarajan D, Shanske S, Vazquez-Memije M, De Vivo D, DiMauro S. A novel mitochondrial ATPase 6 point mutation in familial bilateral striatal necrosis. Ann Neurol\u20081995; 38: 468\u201372.","DOI":"10.1002\/ana.410380321"},{"key":"2022061621062359300_B23","doi-asserted-by":"crossref","unstructured":"Didenko VV, Boudreaux DJ, Baskin DS. Substantial background reduction in ligase-based apoptosis detection using newly designed hairpin oligoprobes. Biotechniques\u20081999; 27: 1130\u20132.","DOI":"10.2144\/99276bm09"},{"key":"2022061621062359300_B24","doi-asserted-by":"crossref","unstructured":"Gong J, Traganos F, Darzynkiewicz Z. A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal Biochem\u20081994; 218: 314\u201319.","DOI":"10.1006\/abio.1994.1184"},{"key":"2022061621062359300_B25","doi-asserted-by":"crossref","unstructured":"Telford WG, King LE, Fraker PJ. Rapid quantitation of apoptosis in pure and heterogeneous cell populations using flow cytometry. J Immunol Methods\u20081994; 172: 1\u201316.","DOI":"10.1016\/0022-1759(94)90373-5"},{"key":"2022061621062359300_B26","doi-asserted-by":"crossref","unstructured":"DiMauro S, Schon EA. Mitochondorial DNA mutations in human disease. Am J Med Genet\u20082001; 106: 18\u201326.","DOI":"10.1002\/ajmg.1392"},{"key":"2022061621062359300_B27","doi-asserted-by":"crossref","unstructured":"Mattiazzi M, Vijayvergiya C, Gajewski CD, et al. The mtDNA T8993G (NARP) mutation results in an impairment of oxidative phosphorylation that can be improved by antioxidants. Hum Mol Genet\u20082004; 13: 869\u201379.","DOI":"10.1093\/hmg\/ddh103"},{"key":"2022061621062359300_B28","unstructured":"Di X, Nishizaki T, Harada K, Kajiwara K, Nakayama H, Ito H. Proliferative potentials of glioma cells and vascular components determined with monoclonal antibody MIB-1. J Exp Clin Cancer Res\u20081997; 16: 153\u20137."},{"key":"2022061621062359300_B29","doi-asserted-by":"crossref","unstructured":"Warburg O. On the origin cancer cells. Science\u20081956; 123: 309\u201314.","DOI":"10.1126\/science.123.3191.309"},{"key":"2022061621062359300_B30","doi-asserted-by":"crossref","unstructured":"Houstek J, Klement P, Hermanska J, et al. Altered properties of mitochondrial ATP-synthase in patients with a T\u2192G mutation in the ATPase6 (subunit a) gene at position 8993 of mtDNA. Biochim Biophys Acta\u20081995; 1271: 349\u201357.","DOI":"10.1016\/0925-4439(95)00063-A"},{"key":"2022061621062359300_B31","doi-asserted-by":"crossref","unstructured":"Modica-Napolitano JS, Singh KK. Mitochondria as targets for detection and treatment of cancer. Expert Rev Mol Med\u20082002; 2002: 1\u20131932.","DOI":"10.1017\/S1462399402004453"},{"key":"2022061621062359300_B32","unstructured":"Nishikawa M, Nishiguchi S, Shiomi S, et al. Somatic mutation of mitochondrial DNA in cancerous and noncancerous liver tissue in individuals with hepatocellular carcinoma. Cancer Res\u20082001; 61: 1843\u20135."},{"key":"2022061621062359300_B33","unstructured":"Tan DJ, Bai RK, Wong LJ. Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res\u20082002; 62: 972\u20136."},{"key":"2022061621062359300_B34","unstructured":"Wong LJ, Lueth M, Li XN, Lau CC, Vogel H. Detection of mitochondrial DNA mutations in the tumor and cerebrospinal fluid of medulloblastoma patients. Cancer Res\u20082003; 63: 3866\u201371."},{"key":"2022061621062359300_B35","doi-asserted-by":"crossref","unstructured":"Hayashi JI, Takemitu M, Nonaka M. Recovery of the missing tumorigenicity in mitochondrial DNA-less HeLa cells by introduction of mitochondrial DNA from normal human cells. Somat Cell Mol Genet\u20081992; 18: 123\u20139.","DOI":"10.1007\/BF01233159"},{"key":"2022061621062359300_B36","unstructured":"Morais R, Zinkewich-Peotti K, Parent M, Wang H, Babai F, Zollinger M. Tumor-forming ability in athymic nude mice of human cell lines devoid of mitochondrial DNA. Cancer Res\u20081994; 54: 3889\u201396."},{"key":"2022061621062359300_B37","unstructured":"Kobayashi Y, Momoi MY, Tominaga K, et al. Respiration-deficient cells are caused by a single point mutation in the mitochondrial tRNA-Leu (UUR) gene in mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS). Am J Hum Genet\u20081991; 49: 590\u20139."},{"key":"2022061621062359300_B38","doi-asserted-by":"crossref","unstructured":"Copeland WC, Wachsman JT, Johnson FM, Penta JS. Mitochondrial DNA alternations in cancer. Cancer Invest\u20082002; 20: 557\u201369.","DOI":"10.1081\/CNV-120002155"},{"key":"2022061621062359300_B39","doi-asserted-by":"crossref","unstructured":"Simonnet H, Alazard N, Pfeiffer K, et al. Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma. Carcinogenesis\u20082002; 23: 759\u201368.","DOI":"10.1093\/carcin\/23.5.759"},{"key":"2022061621062359300_B40","doi-asserted-by":"crossref","unstructured":"Biswas G, Adebanjo OA, Freedman BD, et al. Retrograde Ca2+ signaling in C2C12 skeletal myocytes in response to mitochondrial genetic and metabolic stress: a novel mode of inter-organelle crosstalk. EMBO J.\u20081999; 18: 522\u201333.","DOI":"10.1093\/emboj\/18.3.522"},{"key":"2022061621062359300_B41","doi-asserted-by":"crossref","unstructured":"Shiraiwa N, Ishii A, Iwamoto H, Mizusawa H, Kagawa Y, Ohta S. Content of mutant mitochondrial DNA and organ dysfunction in a patient with a MELAS subgroup of mitochondrial encephalomyopathies. J Neurol Sci\u20081993; 120: 174\u20139.","DOI":"10.1016\/0022-510X(93)90270-9"},{"key":"2022061621062359300_B42","doi-asserted-by":"crossref","unstructured":"Copeland WC, Wachsman JT, Johnson FM, Penta JS. Mitochondrial DNA alterations in cancer. Cancer Invest\u20082002; 20: 557\u201369.","DOI":"10.1081\/CNV-120002155"},{"key":"2022061621062359300_B43","doi-asserted-by":"crossref","unstructured":"Penta JS, Johnson FM, Wachsman JT, Copeland WC. Mitochondrial DNA in human malignancy. Mutat Res\u20082001; 488: 119\u201333.","DOI":"10.1016\/S1383-5742(01)00053-9"},{"key":"2022061621062359300_B44","doi-asserted-by":"crossref","unstructured":"Singh KK, Russell J, Sigara B, Zhang T, Williams J, Keshav KF. Mitochondrial DNA determines the cellular response to cancer therapeutic agents. Oncogene\u20081999; 18: 6641\u20136.","DOI":"10.1038\/sj.onc.1203056"},{"key":"2022061621062359300_B45","doi-asserted-by":"crossref","unstructured":"Jones JB, Song JJ, Hempen PM, Parmigiani G, Hurban RH, Kern SE. Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature\u20081993; 361: 365\u20139.","DOI":"10.1038\/361365a0"},{"key":"2022061621062359300_B46","doi-asserted-by":"crossref","unstructured":"Wang J, Silva JP, Gustafsson CM, Rustin P, Larsson NG. Increased in vivo apoptosis in cells lacking mitochondrial DNA gene expression. Proc Natl Acad Sci U S A\u20082001; 98: 4038\u201343.","DOI":"10.1073\/pnas.061038798"},{"key":"2022061621062359300_B47","doi-asserted-by":"crossref","unstructured":"Cai J, Wallace DC, Zhivotovsky B, Jones DP. Separation of cytochrome c-dependent caspase activation from thiol-disulfide redox change in cell lacking mitochondria DNA. Free Radic Biol Med\u20082000; 29: 334\u201342.","DOI":"10.1016\/S0891-5849(00)00312-9"},{"key":"2022061621062359300_B48","doi-asserted-by":"crossref","unstructured":"Geromel V, Kadhom N, Cebalos-Picot I, et al. Superoxide-induced massive apoptosis in cultured skin fibroblasts harboring the neurogenic ataxia retinitis pigmentosa (NARP) mutation in the ATPase-6 gene of the mitochondrial DNA. Hum Mol Genet\u20082001; 10: 1221\u20138.","DOI":"10.1093\/hmg\/10.11.1221"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/65\/5\/1655\/2540447\/1655-1663.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/65\/5\/1655\/2540447\/1655-1663.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T18:45:50Z","timestamp":1655405150000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/65\/5\/1655\/518990\/Positive-Contribution-of-Pathogenic-Mutations-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,1]]},"references-count":48,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2005,3,7]]},"published-print":{"date-parts":[[2005,3,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-04-2012","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22364387.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22364387","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6494165","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6494165.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,1]]}}}